Levisonics Inc.

New Orleans, LA

UEI
GFC8EGJU6VZ5
CAGE
7VR81
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
levisonics.com
Founded
2016
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

About the company

Levisonics Inc., doing business as Levisonics, is a woman-owned small business and manufacturer of medical devices specializing in innovative blood coagulation analysis technology. Registered to receive federal awards since June 2017, Levisonics has developed a proprietary acoustic tweezing spectroscopy (ATS) platform for non-contact analysis of blood coagulation properties. The company's technology aims to revolutionize coagulation testing by providing comprehensive coagulation profiles from a single drop of whole blood, addressing the need for more convenient and less invasive testing methods, particularly for vulnerable patient populations like neonates and children.

Through several federal grant awards, Levisonics has been advancing its ATS platform for various applications in coagulation monitoring and analysis. The National Heart Lung and Blood Institute awarded the company a $299,309 grant to develop a point-of-care coagulation analyzer for hemophilia patients, while the Defense Health Agency provided a $4,313,357 grant for creating a diagnostic and management system for trauma-related coagulation disorders. The National Science Foundation supported Levisonics with a $998,857 cooperative agreement to develop a non-contact platform for low-volume blood coagulation analysis, aiming to decrease diagnostic response times and lower analysis costs. Additionally, the National Institute of Biomedical Imaging and Bioengineering funded a project to develop a home-use monitoring device for anticoagulant therapy. These grants, spanning both civilian and defense agencies, demonstrate Levisonics' commitment to advancing coagulation testing technology across various healthcare settings and patient populations.

Quick answers

Is Levisonics Inc. registered in SAM.gov?

Yes. Levisonics Inc.'s SAM.gov registration is active through March 17, 2027.

What is Levisonics Inc.'s CAGE code?

Levisonics Inc.'s CAGE code is 7VR81, and its Unique Entity ID (UEI) is GFC8EGJU6VZ5.

What is Levisonics Inc.'s most recent federal award?

Levisonics Inc.'s most recent federal grant award is Coagulation monitoring in hemophilia via acoustic tweezing spectroscopy (R43HL174341), from National Heart Lung and Blood Institute (NIH), on May 17, 2024.

On GovTribe

See Levisonics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe